Lasa Supergenerics is currently trading at Rs. 41.05, up by 1.95 points or 4.99% from its previous closing of Rs. 39.10 on the BSE.
The scrip opened at Rs. 41.05 and has touched a high and low of Rs. 41.05 and Rs. 41.05 respectively. So far 2730 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 44.00 on 17-Feb-2020 and a 52 week low of Rs. 9.48 on 06-Aug-2019.
Last one week high and low of the scrip stood at Rs. 44.00 and Rs. 36.00 respectively. The current market cap of the company is Rs. 166.96 crore.
The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 0.03% and 63.17% respectively.
Lasa Supergenerics has received an approval for acquisition of Harishree Aromatics and Chemicals through Scheme of Amalgamation. The Board of Directors of the company at its meeting held on February 22, 2020, considered and approved the same. The board also approved the appointment of Merchant Bankers and other consultants to scheme.
The Board has decided to discuss and deliberate on the proposed scheme of amalgamation, along with other relevant documents in detail in due course.
Lasa Supergenerics, pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1536.00 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1406.00 |
Zydus Lifesciences | 1005.15 |
Lupin | 1647.60 |
View more.. |